Clinical Trial Update: Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating trastuzumab with either chemotherapy or endocrine therapy for metastatic Luminal B2 breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED